FRANKLYN GERGITS

Allopathic & Osteopathic Physicians|Otolaryngology SCOTTSDALE, AZ NPI 1790781250

General Payments — all program years on this page

$12,786.73

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 255
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $466.07 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $466.0719

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
OptiNose US, Inc. $197.707
GENZYME CORPORATION $178.967
Phadia US Inc. $43.872
GlaxoSmithKline, LLC. $32.142
Stryker Corporation $13.401

By program year

Program yearAmountRecords
2018 $5,529.1553
2019 $1,536.4746
2020 $554.7232
2021 $3,727.7451
2022 $831.3547
2023 $141.237
2024 $466.0719

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1067578920 Phadia US Inc. $22.28 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1067578922 Phadia US Inc. $21.59 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116140880 GlaxoSmithKline, LLC. $15.23 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116479429 GlaxoSmithKline, LLC. $16.91 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119836257 Stryker Corporation $13.40 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139669938 GENZYME CORPORATION $26.20 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139669950 GENZYME CORPORATION $24.53 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139669980 GENZYME CORPORATION $36.01 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139669982 GENZYME CORPORATION $23.98 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670026 GENZYME CORPORATION $29.62 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670038 GENZYME CORPORATION $8.02 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670040 GENZYME CORPORATION $30.60 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142188034 Optinose US, Inc. $7.77 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142188038 Optinose US, Inc. $12.36 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142188052 Optinose US, Inc. $7.30 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142188074 Optinose US, Inc. $7.07 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142188076 Optinose US, Inc. $8.17 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142188088 Optinose US, Inc. $17.42 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142188108 Optinose US, Inc. $137.61 09/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.